MedTrace Logo

A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris

NCT02249104 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2022-08-23

Study results available
· View outcomes & findings →

Summary

The goal of this study is to evaluate a complete topical acne regimen consisting of a prescription acne medication (Epiduo® Gel) and an acne-specific cleanser (Cetaphil® DermaControl™ Foam Wash) and moisturizer with sunscreen (Cetaphil® DermaControl™ Moisturizer SPF 30) for safety, efficacy and patient satisfaction in student athletes with acne vulgaris.

Conditions

  • Acne Vulgaris

Interventions

DRUG

Adapalene/benzoyl peroxide gel, 0.1%/2.5%

Topical AV therapy

OTHER

Cetaphil Acne Regimen

Cleanse, Moisturize, and Protect

Sponsors & Collaborators

  • Galderma R&D

    lead INDUSTRY

Principal Investigators

  • Edward Lain, MD · Pflugerville Dermatology Clinical Research

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2015-02-28
Completion
2015-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02249104 on ClinicalTrials.gov